BioSpace News Archive

Synergy Laboratories (Synergy) is adding a new testing platform to augment its vital COVID-19 diagnostic capabilities. Over the last 8 weeks Synergy has been able to serve first line responders, healthcare providers, hospitals, clinics and nursing homes all across the Gulf Coast and throughout the State of Alabama.

SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD; OTCQB: SQIDF), today reported its financial and operational results for the three and six months ended March 31, 2020 . SQI is a Toronto -based life sciences and diagnostics company that develops and commercializes proprietary technologies and products fo

UNITY Biotechnology today announced the appointment of Anirvan Ghosh, Ph.D., as CEO and member of the Board of Directors, effective March 30, 2020.

RESTORE Orthopedics & Spine Center today announced the acquisition of the revolutionary EOS® imaging System, the first technology capable of providing full body 2D/3D images of patients using low-dose radiation

Needle-free Vaxxas HD-MAP can enhance routine vaccination with potential to revolutionize vaccination in pandemic response; produce more patient-doses from limited quantities of vaccine, distribution without refrigeration, and potential for self-administration.

Beckman Coulter Life Sciences today announced RNAdvance Viral XP has been added to the list of acceptable extraction methods for use in the Centers for Disease Control’s EUA-authorized COVID-19 test referenced in the FDA’s FAQ on testing for SARS-CoV-2

Cellulotech, a company focused on research and development around cellulose, today announced that paper treated with the team’s revolutionary chromatogeny technology has passed the blood/fluid resistance (ASTM F1862) test in an independent United States laboratory.

In honor of Oncology Nursing Month, the Oncology Nursing Society announced the two awardees selected in the Johnson & Johnson Nurses Innovate QuickFire Challenge in Oncology.

Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the Quest Diagnostics Self-collection Kit for COVID-19 (self-collection kit)

Kodiak Sciences Inc., a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, announced that management will present at the following upcoming virtual investor conferences